Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Identification of CYP1A5 as the CYP1A Enzyme Mainly Responsible for Uroporphyrinogen Oxidation Induced by Ah Receptor Ligands in Chicken Liver and Kidney

Peter R. Sinclair, Nadia Gorman, Heidi S. Walton, Jacqueline F. Sinclair, Charis A. Lee and Arleen B. Rifkind
Drug Metabolism and Disposition July 1997, 25 (7) 779-0783;
Peter R. Sinclair
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadia Gorman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi S. Walton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacqueline F. Sinclair
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charis A. Lee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arleen B. Rifkind
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Uroporphyrinogen is an intermediate of the heme biosynthetic pathway. The oxidation of uroporphyrinogen to uroporphyrin (UROX) has been demonstrated to be catalyzed by mammalian CYP1A2. This reaction has an important role in uroporphyria caused by halogenated aromatic compounds. Two CYP enzymes induced by Ah receptor ligands were purified recently from chick embryo liver. One, designated CYP1A5, was preferentially active in arachidonic acid epoxygenation and the other, designated CYP1A4, in 7-ethoxyresorufin deethylase (EROD) and aryl hydrocarbon hydroxylase (AHH), reactions mainly catalyzed by CYP1A1 in rodents. The amino acid sequences of both CYP1A5 and CYP1A4 are more similar to CYP1A1 than to 1A2, and neither can be classified as an ortholog of mammalian CYP1A1 or 1A2. Here we report that reconstituted purified CYP1A5 was eight times more active than CYP1A4 in catalyzing UROX. The stimulation of UROX by 3,4,3′,4′-tetrachlorobiphenyl that has been observed in microsomes was also observed with the reconstituted enzymes. Similar dose response relationships were found for induction of UROX and EROD in both chick embryo liver microsomes and in cultured chick hepatocytes, indicating coinduction of CYP1A5 and CYP1A4. UROX was induced by the Ah receptor ligand, 3-methylcholanthrene, in chicken kidney as well as liver. The findings reported here and other evidence that CYP1A4 and CYP1A5 tend to exhibit CYP1A1 and 1A2-like enzyme activites, respectively, indicate that the division of some enzyme activities among CYP1A enzymes applies to different vertebrate classes.

Footnotes

  • Send reprint requests to: P. Sinclair, VA Medical Center (151), White River Junction, VT 05009-0001. E-mail:psinc{at}Dartmouth.edu.

  • This study was funded by Grants ES03606 (A.B.R.) and ES06203 (P.R.S.) from the National Institutes of Health and by research funds from the Department of Veterans Affairs.

  • This work was presented as a poster at the XthInternational Symposium on Microsomes and Drug Oxidations, Toronto, Canada, July, 1994.

  • ↵2 Sinclair, P, Gorman, N and Lambrecht, R., unpublished observations (1993).

  • ↵3 Hirada, K., C. A. Lee, and A. B. Rifkind, unpublished observations (1994).

  • ↵4 Gilday, D. and A. B. Rifkind, unpublished observations (1995).

  • Abbreviations used are::
    TCDD
    2,3,7,8-tetrachlorodibenzo-p-dioxin
    CYP
    cytochrome P450
    EROD
    ethoxyresorufin deethylase
    UROX
    uroporphyrinogen oxidation
    TCB
    3,4,3′,4′-tetrachlorobiphenyl
    CYP1A5 and CYP1A4
    CYP1A enzymes isolated from TCDD-treated chick embryos previously known as TCDDAA and TCDDAHH, respectively (11)
    AHH
    aryl hydrocarbon hydroxylase
    AA
    arachidonic acid
    • Received August 16, 1996.
    • Accepted March 27, 1997.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 7
1 Jul 1997
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of CYP1A5 as the CYP1A Enzyme Mainly Responsible for Uroporphyrinogen Oxidation Induced by Ah Receptor Ligands in Chicken Liver and Kidney
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Identification of CYP1A5 as the CYP1A Enzyme Mainly Responsible for Uroporphyrinogen Oxidation Induced by Ah Receptor Ligands in Chicken Liver and Kidney

Peter R. Sinclair, Nadia Gorman, Heidi S. Walton, Jacqueline F. Sinclair, Charis A. Lee and Arleen B. Rifkind
Drug Metabolism and Disposition July 1, 1997, 25 (7) 779-0783;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Identification of CYP1A5 as the CYP1A Enzyme Mainly Responsible for Uroporphyrinogen Oxidation Induced by Ah Receptor Ligands in Chicken Liver and Kidney

Peter R. Sinclair, Nadia Gorman, Heidi S. Walton, Jacqueline F. Sinclair, Charis A. Lee and Arleen B. Rifkind
Drug Metabolism and Disposition July 1, 1997, 25 (7) 779-0783;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Improved CYP Reaction Phenotyping
  • Multiple-Concentration Chemical Inhibition Design
  • New Dog P450 3A98 in Gut
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics